NASDAQ:PETS PetMed Express Q2 2027 Earnings Date & Estimates $1.18 -0.01 (-0.84%) Closing price 04:00 PM EasternExtended Trading$1.18 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. PetMed Express is estimated to report Q2 2027 earnings on Tuesday, November 10, 2026. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ2 2027Announcement DateNovember 10, 2026Conference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from PetMed Express in Q2 2027PetMed Express is expected to post earnings of -$0.11 per share on revenue of $62 million. In the same quarter a year earlier PetMed Express reported -$0.56 per share on revenue of $46.47 million. PetMed Express last reported on August 13, 2026, posting -$0.28 per share and missing the $0.12 consensus estimate. PetMed Express has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.11Expected Revenue$62 millionPrior-Year EPS-$0.56Prior-Year Revenue$46.47 millionExpected Revenue Growth+33.4%Recent Track RecordLast ReportedQ1 2027Last Quarter EPS-$0.28 (Missed by -$0.40)Last Quarter Revenue$41.02 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q2 2027 CallEarnings HistoryCompany ProfileQ1 2027 Earnings ReportQ4 2026 Earnings ReportQ3 2026 Earnings Report PetMed Express Q2 2027 Earnings FAQ When does PetMed Express report Q2 2027 earnings? PetMed Express (NASDAQ:PETS) is estimated to report Q2 2027 earnings on Tuesday, November 10, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is PetMed Express' Q2 2027 earnings call? PetMed Express' Q2 2027 earnings conference call is scheduled for Tuesday, November 10, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for PetMed Express? Analysts expect PetMed Express to post earnings of -$0.11 per share for Q2 2027. How much revenue is PetMed Express expected to report? The consensus revenue estimate for PetMed Express is $62 million for Q2 2027. PetMed Express Earnings HeadlinesPetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026October 27 at 4:15 PM | globenewswire.comPetMed Express consensus price target cut by 34.88% to $1.43October 2, 2026 | msn.comThe chip inside every TeslaEvery Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Starlink dish and AI satellite Elon launches. When Nvidia tried to buy the company, Elon reportedly fought the deal. Now his filing for 1,000,000 satellites could expand its revenue stream sharply. Dylan believes the stock could see significant movement starting December 8th.October 29 at 1:00 AM | Behind the Markets (Ad)PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | globenewswire.comPetMed Express Amends Plan for New CEO Equity AwardsSeptember 28, 2026 | tipranks.comAnalysts Conflicted on These Healthcare Names: Petmed Express (PETS) and Accendra Health (ACH)September 22, 2026 | theglobeandmail.comSee More PetMed Express Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email. Email Address About PetMed ExpressPetMed Express (NASDAQ:PETS), doing business as PetMeds, is an online retailer of prescription and nonprescription medications and health products for dogs, cats and other household pets. The company offers products used to treat or prevent conditions such as allergies, infections, parasites and chronic illnesses, including prescription medicines, flea and tick treatments, heartworm preventatives, supplements and other animal-health products. In addition to medications, PetMeds sells pet food, treats, vitamins, wellness products and selected supplies. Customers can place orders through the company’s website and other direct-to-consumer channels, with prescription orders generally requiring authorization from a licensed veterinarian. PetMeds primarily serves pet owners in the United States. Founded in 1996 and previously known as 1-800-PetMeds, the company has built its business around convenient home delivery and consumer access to pet-health products. PetMed Express is headquartered in Delray Beach, Florida, and its common stock trades on the Nasdaq Capital Market under the symbol PETS.View PetMed Express ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Where's the Beef? Trian-Led Buyout Proposal Values Wendy's at $1.4B, But Is It Enough?Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps GrowingPlugging In: Vertiv Cashes In On AI DemandGE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.Phillips 66 Posts Strong Earnings But the Stock Doesn't CareConstellation Energy's Nuclear Expansion Gets a $5 Billion Opening, Not a GuaranteeVisa's Toll Booth Keeps Collecting, But the Price Is Rising Upcoming Earnings Colgate-Palmolive (10/30/2026)BP (10/30/2026)Chevron (10/30/2026)ExxonMobil (10/30/2026)NatWest Group (10/30/2026)AbbVie (10/30/2026)AstraZeneca (10/30/2026)Regeneron Pharmaceuticals (10/30/2026)Sanofi (10/30/2026)Canadian National Railway (10/30/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
